Back to Home
Online Article

New and Approved: FDA’s 2024 Drug Lineup (Pharmacy Technician Credit)

Release Date

January 6, 2025

Expiration Date

January 7, 2026

Credits

1.5 On-Demand

Topics

General Pharmacy

Program Description

The United States Food and Drug Administration approves a wide range of new drugs every year. Pharmacists play a crucial role in the health care team through their expertise on these newly approved medications. With knowledge of key mechanisms of action and potential adverse effects of newly approved drugs, pharmacists can provide patients with the best care possible. This activity will explore select medications to highlight important characteristics, such as mechanism of action, dosing, administration, safety, and efficacy. Pharmacists must stay abreast of the nuances in indications and the potential role of new medications to continue optimizing patient care.

Target Audience: Pharmacy technicians
Type of Activity: Knowledge
Release date: January 6, 2025
Expiration date: January 6, 2026
Learner level: Foundational
Time to complete activity:
1.5 hours
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

  • Identify the clinical indications and common adverse effects of the new drugs approved by the US Food and Drug Administration in 2024
  • Examine the recommended dosing, administration, and other clinical pearls for the drugs reviewed
New and Approved: FDA’s 2024 Drug Lineup (Pharmacy Technician Credit)

GET STARTED WITH THIS PROGRAM:

Register now to gain access to this program.

Create AccountAlready Registered? Login Here

This activity is supported by MJH Life Sciences®, the parent company of PTCE.

What's Included
  • Access your activities anytime, anywhere, with a computer, tablet or smartphone
  • Free access with a PTCE account
  • Pharmacy education designed to improve patient care

Course

New and Approved: FDA’s 2024 Drug Lineup (Pharmacy Technician Credit)

Create Account